ATE366566T1 - Zusammensetzung zur depigmentierung der haut, die adapalen und mindestens ein depigmentierungsmittel enthält - Google Patents

Zusammensetzung zur depigmentierung der haut, die adapalen und mindestens ein depigmentierungsmittel enthält

Info

Publication number: ATE366566T1
Authority: AT; Austria
Prior art keywords: depigmenting; adapalen; composition; skin containing; agent
Prior art date: 2002-09-05

Application number

AT03750634T

Other languages

English (en)

Inventor

Isabelle Pelisson

Andre Jomard

Original Assignee

Galderma Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-05

Filing date

2003-09-01

Publication date

2007-08-15

2003-09-01 Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev

2007-08-15 Application granted granted Critical

2007-08-15 Publication of ATE366566T1 publication Critical patent/ATE366566T1/de

Links

LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
239000007854 depigmenting agent Substances 0.000 title 1
206010008570 Chloasma Diseases 0.000 abstract 2
QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 abstract 2
208000003351 Melanosis Diseases 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
229960002916 adapalene Drugs 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 abstract 1
230000000475 sunscreen effect Effects 0.000 abstract 1
239000000516 sunscreening agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Birds (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Toxicology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT03750634T 2002-09-05 2003-09-01 Zusammensetzung zur depigmentierung der haut, die adapalen und mindestens ein depigmentierungsmittel enthält ATE366566T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0211022		2002-09-05
US41135002P	2002-09-18	2002-09-18

Publications (1)

Publication Number	Publication Date
ATE366566T1 true ATE366566T1 (de)	2007-08-15

Family

ID=31979939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03750634T ATE366566T1 (de)	2002-09-05	2003-09-01	Zusammensetzung zur depigmentierung der haut, die adapalen und mindestens ein depigmentierungsmittel enthält

Country Status (19)

Country	Link
US (1)	US20050163731A1 (de)
EP (1)	EP1536763B1 (de)
JP (1)	JP4662769B2 (de)
KR (1)	KR20050057238A (de)
CN (1)	CN100391432C (de)
AT (1)	ATE366566T1 (de)
AU (1)	AU2003270272B2 (de)
BR (1)	BR0313370B1 (de)
CA (1)	CA2495043A1 (de)
CY (1)	CY1107732T1 (de)
DE (1)	DE60314887T2 (de)
DK (1)	DK1536763T3 (de)
ES (1)	ES2289315T3 (de)
MX (1)	MXPA05002064A (de)
PL (1)	PL377106A1 (de)
PT (1)	PT1536763E (de)
RU (1)	RU2317066C2 (de)
WO (1)	WO2004021967A2 (de)
ZA (1)	ZA200501753B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7544674B2 (en)	2002-10-25	2009-06-09	Galderma S.A.	Topical skin care composition
MXPA05005170A (es) *	2002-12-12	2005-10-05	Galderma Res & Dev	Gel despigmentante alcoholico acuoso que contiene un derivado fenolico y un retinoide.
FR2871377B1 (fr) *	2004-06-11	2007-08-24	Galderma Res & Dev	Gel depigmentant hydroalcoolique comprenant du mequinol et de l'adapalene
FR2890314B1 (fr) *	2005-09-02	2009-03-20	Galderma Res & Dev	Compositiondepigmentante de la peau comprenant de l'adapalene au moins un agent depigmentant et au moins un agent anti-inflammatoire
EP1926484A2 (de) *	2005-09-02	2008-06-04	Galderma Research & Development	Depigmentierungszusammensetzung für die haut mit adapalen, mindestens einem depigmentierungsmittel und mindestens einem entzündungshemmer
FR2894820B1 (fr) *	2005-12-15	2008-02-29	Galderma Res & Dev	Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
FR2910320B1 (fr)	2006-12-21	2009-02-13	Galderma Res & Dev S N C Snc	Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr)	2006-12-21	2009-07-10	Galderma Res & Dev S N C Snc	Gel creme comprenant au moins un retinoide et du peroxyde de benzole
JP5646129B2 (ja) *	2007-03-31	2014-12-24	大正製薬株式会社	アダパレン含有外用剤組成物
FR2915682B1 (fr) *	2007-05-04	2009-07-03	Galderma Res & Dev	Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
US9364424B2 (en) *	2007-11-19	2016-06-14	Stiefel Laboratories, Inc.	Topical cosmetic skin lightening compositions and methods of use thereof
FR2931661B1 (fr) *	2008-05-30	2010-07-30	Galderma Res & Dev	Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
FR2931663B1 (fr) *	2008-05-30	2010-07-30	Galderma Res & Dev	Nouvelles compositions depigmentantes anhydre comprenant un derive phenolique solubilise.
FR2949065B1 (fr)	2009-08-17	2011-10-21	Natura Cosmeticos Sa	Complexe eclaircissant la peau, utilisation dudit complexe, composition cosmetique ou pharmaceutique comprenant ledit complexe et procede pour son application
WO2011135090A1 (en) *	2010-04-29	2011-11-03	Galderma Research & Development	Method for treating scars with adapalene 0.3%
FR2969492B1 (fr) *	2010-12-23	2013-07-05	Galderma Res & Dev	Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
RU2450836C1 (ru) *	2011-03-15	2012-05-20	Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды"	Комбинированная мазевая композиция для уменьшения интенсивности локальной гиперпигментации кожи
GB2568758A (en) *	2017-11-28	2019-05-29	Chitty Nicholas	Sun protection and acne treatment and prevention composition
US12133907B2 (en) *	2021-01-07	2024-11-05	Actera Ingredients, Inc.	Lipophilic third generation retinoid

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3856934A (en) *	1970-06-24	1974-12-24	A Kligman	Skin depigmentation
US5194247A (en) *	1989-08-24	1993-03-16	Xina Nair	Synergistic skin depigmentation composition
FR2653336B1 (fr) *	1989-10-20	1994-04-08	Oreal	Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
US5395611A (en) *	1990-04-24	1995-03-07	The Governors Of The University Of Alberta	Phenolic amine depigmenting and antimelanoma agents
FR2714601B1 (fr) *	1993-12-30	1996-02-09	Oreal	Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation.
US6068834A (en) *	1994-03-04	2000-05-30	The Procter & Gamble Company	Skin lightening compositions
FR2723315B1 (fr) *	1994-08-02	1996-10-25	Cird Galderma	Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes
FR2752734B1 (fr) *	1996-09-02	1998-11-06	Cird Galderma	Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf
AU7293398A (en) *	1998-05-07	1999-11-23	Procter & Gamble Company, The	A composition containing an ascorbic acid compound
KR20020047129A (ko) *	1999-08-24	2002-06-21	데이비드 엠 모이어	옥심 화합물 함유 조성물의 국소 적용에 의한 케라틴성조직의 라이트닝 방법
US20030077301A1 (en) *	1999-12-16	2003-04-24	Maibach Howard I.	Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US6358541B1 (en) *	2000-05-03	2002-03-19	David S. Goodman	Topical preparation for the treatment of hair loss
US20030147977A1 (en) *	2000-05-03	2003-08-07	Goodman David S.	Topical preparation for treating acne and hirsutism
DE60106954T2 (de) *	2000-09-11	2005-12-01	Pfizer Products Inc., Groton	Resorcin-derivate
US20030003142A1 (en) *	2001-05-23	2003-01-02	Wortzman Mitchell S.	Composition and method for the treatment of pigmentation disorders
US7189759B2 (en) *	2001-05-23	2007-03-13	Medicis Pharmaceutical Corporation	Compositions for the treatment of pigmentation disorders and methods for their manufacture

2003
- 2003-09-01 PL PL377106A patent/PL377106A1/pl not_active Application Discontinuation
- 2003-09-01 KR KR1020057003877A patent/KR20050057238A/ko not_active Ceased
- 2003-09-01 PT PT03750634T patent/PT1536763E/pt unknown
- 2003-09-01 WO PCT/EP2003/010692 patent/WO2004021967A2/en not_active Ceased
- 2003-09-01 BR BRPI0313370-2A patent/BR0313370B1/pt not_active IP Right Cessation
- 2003-09-01 AU AU2003270272A patent/AU2003270272B2/en not_active Ceased
- 2003-09-01 JP JP2004533511A patent/JP4662769B2/ja not_active Expired - Fee Related
- 2003-09-01 DE DE60314887T patent/DE60314887T2/de not_active Expired - Lifetime
- 2003-09-01 ES ES03750634T patent/ES2289315T3/es not_active Expired - Lifetime
- 2003-09-01 DK DK03750634T patent/DK1536763T3/da active
- 2003-09-01 RU RU2005109553/15A patent/RU2317066C2/ru not_active IP Right Cessation
- 2003-09-01 CN CNB038212447A patent/CN100391432C/zh not_active Expired - Fee Related
- 2003-09-01 AT AT03750634T patent/ATE366566T1/de active
- 2003-09-01 CA CA002495043A patent/CA2495043A1/en not_active Abandoned
- 2003-09-01 MX MXPA05002064A patent/MXPA05002064A/es active IP Right Grant
- 2003-09-01 EP EP03750634A patent/EP1536763B1/de not_active Expired - Lifetime
2005
- 2005-01-26 US US11/042,519 patent/US20050163731A1/en not_active Abandoned
- 2005-03-01 ZA ZA2005/01753A patent/ZA200501753B/en unknown
2007
- 2007-09-12 CY CY20071101173T patent/CY1107732T1/el unknown

Also Published As

Publication number	Publication date
CN1681473A (zh)	2005-10-12
RU2005109553A (ru)	2005-08-20
BR0313370A (pt)	2006-04-18
WO2004021967A2 (en)	2004-03-18
CN100391432C (zh)	2008-06-04
JP2006511466A (ja)	2006-04-06
JP4662769B2 (ja)	2011-03-30
CY1107732T1 (el)	2013-04-18
PL377106A1 (pl)	2006-01-23
PT1536763E (pt)	2007-08-20
EP1536763A2 (de)	2005-06-08
DE60314887T2 (de)	2008-03-13
EP1536763B1 (de)	2007-07-11
ES2289315T3 (es)	2008-02-01
AU2003270272B2 (en)	2008-06-19
DK1536763T3 (da)	2007-11-05
ZA200501753B (en)	2007-01-31
CA2495043A1 (en)	2004-03-18
RU2317066C2 (ru)	2008-02-20
KR20050057238A (ko)	2005-06-16
MXPA05002064A (es)	2005-06-08
AU2003270272A1 (en)	2004-03-29
DE60314887D1 (de)	2007-08-23
BR0313370B1 (pt)	2015-02-24
WO2004021967A3 (en)	2005-02-17
US20050163731A1 (en)	2005-07-28

Legal Events

Date

Code

Title

Description

2007-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1536763

Country of ref document: EP

Publication	Publication Date	Title
CY1107732T1 (el)	2013-04-18	Συνθεση αποπηγμεντωσης για το δερμα περιλαμβανουσα αδαπαλενιο και ενα τουλαχιστον παραγοντα αποπηγμεντωσης
EP2444060A3 (de)	2014-08-27	Zusammensetzung
ATE521326T1 (de)	2011-09-15	Durchscheinende nanoemulsion, verfahren zur deren herstellung, und deren verwendungen in kosmetika, dermatologie und/oder ophtalmologie.
HUP0303665A2 (hu)	2004-03-01	Káliumcsatorna-blokkoló hatású arilezett furán- és tiofén-karbonsavamidok
WO2007002831A3 (en)	2007-06-21	Topical skin treating compostions
DE60111539D1 (de)	2005-07-21	Pharmazeutische zusammensetzung enthaltend ein 5-aminolaevulinsäure-ester als photochemotherapeutikum und ein mucoadhäsivum
IL154888A (en)	2013-12-31	Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
TW200611708A (en)	2006-04-16	Whitening composition containing reduced coenzyme q
GB9918025D0 (en)	1999-09-29	Skin care composition
DE69832710D1 (de)	2006-01-12	Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
AU6200599A (en)	2000-04-17	Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of acomposition for the treatment of ischemic stroke
DE69415018D1 (de)	1999-01-14	Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
MXPA03005510A (es)	2004-04-20	Composiciones y metodos para tratar hiperpigmentacion.
WO2000002593A3 (fr)	2000-08-24	Lotion nettoyante et traitante destinee au traitement des comedons
WO2007047486A3 (en)	2008-05-22	Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites
CA2433343A1 (en)	2002-12-05	Cosmetic compositions containing rosemary extract and dha
DK1716845T3 (da)	2010-06-28	Formulering til dermal anvendelse
EA032573B1 (ru)	2019-06-28	Композиция для осветления кожи, содержащая 4-гексилрезорцин и иломастат
WO2001022917A8 (en)	2002-06-20	Effervescent compositions comprising nimesulide
DE60009652D1 (de)	2004-05-13	Pharmazeutische mischung, die ein profen und weitere aktivsubstanzen enthält
AR030647A1 (es)	2003-08-27	Composicion farmaceutica con actividad de agua especifica
PE20050188A1 (es)	2005-04-19	Monohidrato de 4-ciclopentilresorcinol como agente de despigmentacion
MXPA05002619A (es)	2005-11-04	Composicion y metodo de potenciacion.
ES2065308T3 (es)	1997-01-01	Producto para el moldeado permanente del cabello y nuevos esteres del acido 2-hidroxi-3-mercapto-propionico reductores de la queratina capilar.
TW200701990A (en)	2007-01-16	Composition for improving an area of skin hydration and method thereof